Atlanta Institute of Medicine and Research   Report issue

For profit Phase 2 Phase 3
Founded: Atlanta GA United States (1982)

Organization Overview

First Clinical Trial
2006
NCT00384527
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Atlanta Institute of Medicine and Research

Active Ingredients

Drugs in Phase 3 Trials (2)

nitazoxanide (alinia) (1 trial)

vancomycin (Vancocin) (1 trial)

Drugs in Phase 2 Trials (1)

cx157 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Clostridium Infections (Phase 3)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Treatment-Resistant (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3